Literature DB >> 2345177

Structure of a retinoic acid-responsive gene, MK, which is transiently activated during the differentiation of embryonal carcinoma cells and the mid-gestation period of mouse embryogenesis.

S Matsubara1, M Tomomura, K Kadomatsu, T Muramatsu.   

Abstract

MK is a gene that is expressed temporarily during the early stages of retinoic acid-induced differentiation of embryonal carcinoma (EC) cells and during the mid-gestation period of mouse embryogenesis. The 5'-regions of MK cDNAs and their mRNAs are heterogeneous; so far three kinds of MK cDNAs (MK1, MK2, and MK3) have been isolated. The MK gene was cloned from a genomic DNA library of a BALB/c mouse, and its structure was elucidated. 5'-Region sequences specific for MK1, MK2, and MK3 were arranged in the order of MK3, MK2, and MK1. Then, there was a sequence common to all MK cDNAs consisting of four exons. The results indicate that different species of MK mRNA are generated by the use of alternative promoters and different modes of splicing.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2345177

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Recombinant human midkine stimulates proliferation of articular chondrocytes.

Authors:  Z H Zhang; H X Li; Y P Qi; L J Du; S Y Zhu; M Y Wu; H L Lu; Y Yu; W Han
Journal:  Cell Prolif       Date:  2010-04       Impact factor: 6.831

2.  Protein-bound carbohydrates on cell-surface as targets of recognition: an odyssey in understanding them.

Authors:  T Muramatsu
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

3.  Midkine concentrations in fine-needle aspiration of benign and malignant thyroid nodules.

Authors:  Youn Hee Jee; Francesco S Celi; Maureen Sampson; David B Sacks; Alan T Remaley; Electron Kebebew; Jeffrey Baron
Journal:  Clin Endocrinol (Oxf)       Date:  2015-01-15       Impact factor: 3.478

Review 4.  Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases.

Authors:  D R Jones
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

5.  Chromosomal localization of two cell surface-associated molecules of potential importance in development: midkine (Mdk) and basigin (Bsg).

Authors:  D Simon-Chazottes; S Matsubara; T Miyauchi; T Muramatsu; J L Guénet
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

6.  Mapping the midkine family of developmentally regulated signaling molecules.

Authors:  C L Peichel; S W Scherer; L C Tsui; D R Beier; T F Vogt
Journal:  Mamm Genome       Date:  1993-11       Impact factor: 2.957

Review 7.  Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target.

Authors:  Panagiota S Filippou; George S Karagiannis; Anastasia Constantinidou
Journal:  Oncogene       Date:  2019-12-04       Impact factor: 9.867

Review 8.  Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases.

Authors:  Takashi Muramatsu
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

Review 9.  Midkine: a promising molecule for drug development to treat diseases of the central nervous system.

Authors:  Takashi Muramatsu
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

10.  A high throughput messenger RNA differential display screen identifies discrete domains of gene expression and novel patterning processes along the developing neural tube.

Authors:  David Chambers; Ivor Mason
Journal:  BMC Dev Biol       Date:  2006-02-24       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.